drugset / Trial / NCT06365840
A Study of IMC-001 In Patients With Metastatic Or Locally Advanced TMB-H Solid Tumor
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to determine the efficacy of IMC-001 in metastatic or locally advanced TMB-H solid tumor patients.
Timeline
- Start
- 2025-01-13
- Primary completion
- 2027-06-30
- Completion
- 2029-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | IMC-001 | Monoclonal antibody | 20 mg/kg | Intravenous |
Indications
No indication recorded.